Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|January 11, 2020
Long-Term Ibrutinib Therapy Reverses CD8+ T Cell Exhaustion in B Cell Chronic Lymphocytic LeukaemiaHelen M Parry, Nikhil Mirajkar, Natasha Cutmore, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2015
TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B CellsPatricia K A Mongini, Rashmi Gupta, Erin Boyle, et al.
British Journal of Haematology|June 25, 2008
Pathogenic ATM mutations occur rarely in a subset of multiple myeloma patientsBelinda Austen, Giancarlo Barone, Anne Reiman, et al.
Molecular Cell|July 14, 2015
BOD1L Is Required to Suppress Deleterious Resection of Stressed Replication ForksMartin R Higgs, John J Reynolds, Alicja Winczura, et al.
Blood|August 27, 2010
The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivoVictoria J Weston, Ceri E Oldreive, Anna Skowronska, et al.
Disease Models & Mechanisms|September 24, 2015
T-cell number and subtype influence the disease course of primary chronic lymphocytic leukaemia xenografts in alymphoid miceCeri E Oldreive, Anna Skowronska, Nicholas J Davies, et al.
Plos Genetics|March 19, 2016
A Hypomorphic PALB2 Allele Gives Rise to an Unusual Form of FA-N Associated with Lymphoid Tumour DevelopmentPhilip J Byrd, Grant S Stewart, Anna Smith, et al.
Pageof 6